Skip to main content
Go back to Resources
Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
Keywords:
Go back to Resources
Go back to Resources
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources